| MeSH term | MeSH ID | Detail |
|---|---|---|
| Epiglottitis | D004826 | 1 associated lipids |
| Tick Bites | D064927 | 1 associated lipids |
| Eisenmenger Complex | D004541 | 1 associated lipids |
| Myelitis, Transverse | D009188 | 1 associated lipids |
| Furcation Defects | D017823 | 1 associated lipids |
| Granulomatous Mastitis | D058890 | 1 associated lipids |
| Focal Nodular Hyperplasia | D020518 | 1 associated lipids |
| Syncope, Vasovagal | D019462 | 1 associated lipids |
| Pseudolymphoma | D019310 | 1 associated lipids |
| Achondroplasia | D000130 | 1 associated lipids |
Azithramycine
Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
Cross Reference
Introduction
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Azithramycine?
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (156)
- Clin. Infect. Dis. (64)
- J. Antimicrob. Chemother. (50)
- Others (435)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Azithramycine
PubChem Associated disorders and diseases
What pathways are associated with Azithramycine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Azithramycine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (66)
- J. Antimicrob. Chemother. (25)
- Clin. Infect. Dis. (13)
- Others (151)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Azithramycine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Azithramycine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Azithramycine?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (44)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (10)
- Others (126)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Azithramycine?
Mouse Model
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Azithramycine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Sardana K et al. | An observational study of the efficacy of azithromycin in erythema annulare centrifugum. | 2018 | Clin. Exp. Dermatol. | pmid:29297941 |
| Bakar O et al. | The effect of azithromycin on reactive oxygen species in rosacea. | 2007 | Clin. Exp. Dermatol. | pmid:17244346 |
| Fuentelsaz V et al. | Rosacea fulminans in pregnancy: successful treatment with azithromycin. | 2011 | Clin. Exp. Dermatol. | pmid:21714808 |
| López-Lerma I et al. | Occupational airborne contact dermatitis from azithromycin. | 2009 | Clin. Exp. Dermatol. | pmid:19486052 |
| Kus S et al. | Comparison of efficacy of azithromycin vs. doxycycline in the treatment of acne vulgaris. | 2005 | Clin. Exp. Dermatol. | pmid:15807672 |
| Chaudhry SI et al. | A rash on the back. Diagnosis: confluent and reticulated papillomatosis (CRP) of Gougerot and Carteaud. | 2006 | Clin. Exp. Dermatol. | pmid:16901326 |
| Gruber F et al. | Treatment of confluent and reticulated papillomatosis with azithromycin. | 1998 | Clin. Exp. Dermatol. | pmid:9894368 |
| Weckmann M et al. | Treatment with rhDNase in patients with cystic fibrosis alters in-vitro CHIT-1 activity of isolated leucocytes. | 2016 | Clin. Exp. Immunol. | pmid:27324468 |
| Iwamoto S et al. | The effect of azithromycin on the maturation and function of murine bone marrow-derived dendritic cells. | 2011 | Clin. Exp. Immunol. | pmid:22059997 |
| Buehring I et al. | Chronic sinusitis refractory to standard management in patients with humoral immunodeficiencies. | 1997 | Clin. Exp. Immunol. | pmid:9328124 |
| Iwamoto S et al. | Efficacy of azithromycin in preventing lethal graft-versus-host disease. | 2013 | Clin. Exp. Immunol. | pmid:23379441 |
| Sugiyama K et al. | Differing effects of clarithromycin and azithromycin on cytokine production by murine dendritic cells. | 2007 | Clin. Exp. Immunol. | pmid:17302905 |
| Rotschild M et al. | Autoantibodies against bactericidal/permeability-increasing protein (BPI-ANCA) in cystic fibrosis patients treated with azithromycin. | 2005 | Clin. Exp. Med. | pmid:16096858 |
| Jones S et al. | Trachoma in Far North Queensland: an example of poor population health practice. | 2013 | Clin. Experiment. Ophthalmol. | pmid:23145782 |
| Lockington D | Oral azithromycin and blepharitis: symptoms and signs improve, so where are the publications? | 2016 | Clin. Experiment. Ophthalmol. | pmid:27356302 |
| Shah SA et al. | Meibomian gland dysfunction: azithromycin and objective improvement in outcomes in posterior blepharitis. | 2016 | Clin. Experiment. Ophthalmol. | pmid:27314917 |
| Heriot WJ et al. | Ocular involvement in a patient with Legionella longbeachae 1 infection. | 2014 | Clin. Experiment. Ophthalmol. | pmid:24650007 |
| Al-Hity A and Lockington D | Oral azithromycin as the systemic treatment of choice in the treatment of meibomian gland disease. | 2016 | Clin. Experiment. Ophthalmol. | pmid:26441357 |
| Martinez MA et al. | Clinical and histologic features of azithromycin-induced liver injury. | 2015 | Clin. Gastroenterol. Hepatol. | pmid:25111234 |
| Arnez M | Antibiotic treatment of children with erythema migrans. | 2007 | Clin. Infect. Dis. | pmid:17366464 |
| González-Beiras C et al. | Single-Dose Azithromycin for the Treatment of Haemophilus ducreyi Skin Ulcers in Papua New Guinea. | 2017 | Clin. Infect. Dis. | pmid:29020192 |
| Frenck RW et al. | Short-course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents. | 2004 | Clin. Infect. Dis. | pmid:15034826 |
| Schwebke JR et al. | Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens--a randomized clinical trial. | 2011 | Clin. Infect. Dis. | pmid:21288838 |
| Hicks LA et al. | US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011. | 2015 | Clin. Infect. Dis. | pmid:25747410 |
| Plouffe JF et al. | Azithromycin in the treatment of Legionella pneumonia requiring hospitalization. | 2003 | Clin. Infect. Dis. | pmid:14614670 |
| Kober MB and Mason BA | Colonization of the female genital tract by resistant Ureaplasma urealyticum treated successfully with azithromycin. | 1998 | Clin. Infect. Dis. | pmid:9709898 |
| Adachi JA et al. | Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico. | 2003 | Clin. Infect. Dis. | pmid:14557959 |
| Adal KA et al. | Photo quiz. Bacillary angiomatosis. | 1995 | Clin. Infect. Dis. | pmid:7727641 |
| Bissessor M et al. | Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens. | 2015 | Clin. Infect. Dis. | pmid:25537875 |
| Doan T et al. | Gut Microbial Diversity in Antibiotic-Naive Children After Systemic Antibiotic Exposure: A Randomized Controlled Trial. | 2017 | Clin. Infect. Dis. | pmid:28402408 |
| Gagliotti C et al. | Macrolide prescriptions and erythromycin resistance of Streptococcus pyogenes. | 2006 | Clin. Infect. Dis. | pmid:16575736 |
| Chou HW et al. | Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study. | 2015 | Clin. Infect. Dis. | pmid:25409476 |
| Riddle MS et al. | Trial Evaluating Ambulatory Therapy of Travelers' Diarrhea (TrEAT TD) Study: A Randomized Controlled Trial Comparing 3 Single-Dose Antibiotic Regimens With Loperamide. | 2017 | Clin. Infect. Dis. | pmid:29029033 |
| Taylor WR et al. | Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia. | 1999 | Clin. Infect. Dis. | pmid:10028075 |
| Bissessor M et al. | Persistence of Neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea is influenced by antibiotic susceptibility and reinfection. | 2015 | Clin. Infect. Dis. | pmid:25371490 |
| Haggerty CL and Ness RB | Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials. | 2007 | Clin. Infect. Dis. | pmid:17342647 |
| Stoner BP | Current controversies in the management of adult syphilis. | 2007 | Clin. Infect. Dis. | pmid:17342666 |
| Geisler WM | Management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: evidence reviewed for the 2006 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. | 2007 | Clin. Infect. Dis. | pmid:17342671 |
| Katz AR et al. | Neisseria gonorrhoeae with high-level resistance to azithromycin: case report of the first isolate identified in the United States. | 2012 | Clin. Infect. Dis. | pmid:22184617 |
| Dawson CR et al. | A comparison of oral azithromycin with topical oxytetracycline/polymyxin for the treatment of trachoma in children. | 1997 | Clin. Infect. Dis. | pmid:9114186 |
| Goins WP et al. | A comparison of 2 strategies to prevent infection following pertussis exposure in vaccinated healthcare personnel. | 2012 | Clin. Infect. Dis. | pmid:22238169 |
| Brown BA et al. | Relationship of adverse events to serum drug levels in patients receiving high-dose azithromycin for mycobacterial lung disease. | 1997 | Clin. Infect. Dis. | pmid:9142801 |
| Fry AM et al. | Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal. | 2002 | Clin. Infect. Dis. | pmid:12145722 |
| Park J et al. | Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense. | 2017 | Clin. Infect. Dis. | pmid:28011609 |
| Esposito S et al. | Acute tonsillopharyngitis associated with atypical bacterial infection in children: natural history and impact of macrolide therapy. | 2006 | Clin. Infect. Dis. | pmid:16779748 |
| Chidambaram JD et al. | Mass antibiotic treatment and community protection in trachoma control programs. | 2004 | Clin. Infect. Dis. | pmid:15494901 |
| Kim YS et al. | A comparative trial of a single dose of azithromycin versus doxycycline for the treatment of mild scrub typhus. | 2004 | Clin. Infect. Dis. | pmid:15494910 |
| Jensen JS et al. | Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. | 2008 | Clin. Infect. Dis. | pmid:18990060 |
| Kong FY et al. | Azithromycin versus doxycycline for the treatment of genital chlamydia infection: a meta-analysis of randomized controlled trials. | 2014 | Clin. Infect. Dis. | pmid:24729507 |
| Ghaffar F et al. | Effects of large dosages of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, nonpneumococcal alpha-hemolytic streptococci, and Staphylococcus aureus in children with acute otitis media. | 2002 | Clin. Infect. Dis. | pmid:11981724 |
| Edelstein PH | Predicting the emergence of antimicrobial resistance. | 2002 | Clin. Infect. Dis. | pmid:11981741 |
| Falagas ME and Klempner MS | Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin. | 1996 | Clin. Infect. Dis. | pmid:8722936 |
| Murphy GS et al. | Ciprofloxacin- and azithromycin-resistant Campylobacter causing traveler's diarrhea in U.S. troops deployed to Thailand in 1994. | 1996 | Clin. Infect. Dis. | pmid:8722958 |
| Guchev IA et al. | Two regimens of azithromycin prophylaxis against community-acquired respiratory and skin/soft-tissue infections among military trainees. | 2004 | Clin. Infect. Dis. | pmid:15095213 |
| Solera J et al. | Azithromycin and gentamicin therapy for the treatment of humans with brucellosis. | 2001 | Clin. Infect. Dis. | pmid:11170962 |
| Rennie RP and Ibrahim KH | Antimicrobial resistance in Haemophilus influenzae: how can we prevent the inevitable? Commentary on antimicrobial resistance in H. influenzae based on data from the TARGETed surveillance program. | 2005 | Clin. Infect. Dis. | pmid:16032558 |
| Gill DA et al. | Complete elimination is a difficult goal for trachoma programs in severely affected communities. | 2008 | Clin. Infect. Dis. | pmid:18194094 |
| Hoge CW et al. | Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. | 1998 | Clin. Infect. Dis. | pmid:9502453 |
| Oldfield EC et al. | Once weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS: a randomized, double-blind, placebo-controlled multicenter trial. | 1998 | Clin. Infect. Dis. | pmid:9524832 |
| Wormser GP et al. | Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection. | 2010 | Clin. Infect. Dis. | pmid:20047477 |
| Schwebke JR and Desmond RA | A randomized trial of the duration of therapy with metronidazole plus or minus azithromycin for treatment of symptomatic bacterial vaginosis. | 2007 | Clin. Infect. Dis. | pmid:17173219 |
| Fogarty C et al. | Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin. | 2000 | Clin. Infect. Dis. | pmid:10987733 |
| Eschenbach DA | Bacterial vaginosis: resistance, recurrence, and/or reinfection? | 2007 | Clin. Infect. Dis. | pmid:17173220 |
| Kuschner RA et al. | Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. | 1995 | Clin. Infect. Dis. | pmid:8527539 |
| Tribble DR et al. | Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen. | 2007 | Clin. Infect. Dis. | pmid:17205438 |
| Casey JR and Pichichero ME | Higher dosages of azithromycin are more effective in treatment of group A streptococcal tonsillopharyngitis. | 2005 | Clin. Infect. Dis. | pmid:15909262 |
| DuPont HL | Azithromycin for the self-treatment of traveler's diarrhea. | 2007 | Clin. Infect. Dis. | pmid:17205439 |
| Amábile-Cuevas CF et al. | Comparative in vitro activity of moxifloxacin by E-test against Streptococcus pyogenes. | 2001 | Clin. Infect. Dis. | pmid:11249826 |
| Donowitz GR | Tissue-directed antibiotics and intracellular parasites: complex interaction of phagocytes, pathogens, and drugs. | 1994 | Clin. Infect. Dis. | pmid:7893881 |
| Verdon MS et al. | Pilot study of azithromycin for treatment of primary and secondary syphilis. | 1994 | Clin. Infect. Dis. | pmid:7811868 |
| Sykes A et al. | Azithromycin plus artesunate versus artemether-lumefantrine for treatment of uncomplicated malaria in Tanzanian children: a randomized, controlled trial. | 2009 | Clin. Infect. Dis. | pmid:19769536 |
| Malhotra-Kumar S and Goossens H | Mass azithromycin distribution and emerging resistance: taking a minimum harms approach. | 2013 | Clin. Infect. Dis. | pmid:23487372 |
| Coles CL et al. | Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment. | 2013 | Clin. Infect. Dis. | pmid:23487375 |
| Joloba ML et al. | Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media. | 2001 | Clin. Infect. Dis. | pmid:11588694 |
| Ghanem KG and Workowski KA | Management of adult syphilis. | 2011 | Clin. Infect. Dis. | pmid:22080265 |
| Manhart LE et al. | Mycoplasma genitalium: should we treat and how? | 2011 | Clin. Infect. Dis. | pmid:22080266 |
| Gray GC et al. | Randomized, placebo-controlled clinical trial of oral azithromycin prophylaxis against respiratory infections in a high-risk, young adult population. | 2001 | Clin. Infect. Dis. | pmid:11528569 |
| Sanders JW et al. | Azithromycin and loperamide are comparable to levofloxacin and loperamide for the treatment of traveler's diarrhea in United States military personnel in Turkey. | 2007 | Clin. Infect. Dis. | pmid:18688944 |
| Sirinavin S et al. | Norfloxacin and azithromycin for treatment of nontyphoidal salmonella carriers. | 2003 | Clin. Infect. Dis. | pmid:12942401 |
| Doern GV | Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. | 2001 | Clin. Infect. Dis. | pmid:11524718 |
| Rocha JL | Correct dose of azithromycin for patients scheduled to undergo dental procedures. | 2003 | Clin. Infect. Dis. | pmid:12955653 |
| Spooner K et al. | Azithromcyin might not protect against Treponema pallidum infection or reactivation in HIV type 1-infected patients. | 2005 | Clin. Infect. Dis. | pmid:16007551 |
| Benson CA | Treatment of disseminated disease due to the Mycobacterium avium complex in patients with AIDS. | 1994 | Clin. Infect. Dis. | pmid:8204776 |
| Kalonji LM et al. | Invasive Salmonella Infections at Multiple Surveillance Sites in the Democratic Republic of the Congo, 2011-2014. | 2015 | Clin. Infect. Dis. | pmid:26449951 |
| Keenan JD et al. | Childhood mortality in a cohort treated with mass azithromycin for trachoma. | 2011 | Clin. Infect. Dis. | pmid:21427395 |
| Katz AR et al. | Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016. | 2017 | Clin. Infect. Dis. | pmid:28549097 |
| Karlowsky JA et al. | Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002). | 2003 | Clin. Infect. Dis. | pmid:12684907 |
| Cascio A et al. | Clarithromycin versus azithromycin in the treatment of Mediterranean spotted fever in children: a randomized controlled trial. | 2002 | Clin. Infect. Dis. | pmid:11740701 |
| Walker J et al. | Mycoplasma genitalium incidence, organism load, and treatment failure in a cohort of young Australian women. | 2013 | Clin. Infect. Dis. | pmid:23300236 |
| Hughes WT et al. | Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection. | 2005 | Clin. Infect. Dis. | pmid:15614703 |
| Mena LA et al. | A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. | 2009 | Clin. Infect. Dis. | pmid:19438399 |
| Jensen JS | Single-dose azithromycin treatment for Mycoplasma genitalium-positive urethritis: best but not good enough. | 2009 | Clin. Infect. Dis. | pmid:19438400 |
| Griffith DE et al. | Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virus. | 1996 | Clin. Infect. Dis. | pmid:8922790 |
| Ward TT et al. | Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research Consortium. | 1998 | Clin. Infect. Dis. | pmid:9827282 |
| Koepke R et al. | Widespread Bordetella parapertussis Infections-Wisconsin, 2011-2012: Clinical and Epidemiologic Features and Antibiotic Use for Treatment and Prevention. | 2015 | Clin. Infect. Dis. | pmid:26113655 |
| Griffith DE et al. | Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease. | 2001 | Clin. Infect. Dis. | pmid:11340525 |
| Tan JS et al. | Persistently positive culture results in a patient with community-acquired pneumonia due to Legionella pneumophila. | 2001 | Clin. Infect. Dis. | pmid:11340527 |
| Carbon C | Pharmacodynamics of macrolides, azalides, and streptogramins: effect on extracellular pathogens. | 1998 | Clin. Infect. Dis. | pmid:9675445 |
| Guerra LG et al. | Rapid response of AIDS-related bacillary angiomatosis to azithromycin. | 1993 | Clin. Infect. Dis. | pmid:8399879 |
| Noedl H et al. | Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand. | 2006 | Clin. Infect. Dis. | pmid:17051490 |